pfizer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

pfizer
Jan 13, 2025, 15:18 | Blog
Chris Boshoff: Positive phase 3 results for Pfizer’s PD-1 inhibitor in high-risk NMIBC
Chris Boshoff, Chief Oncology Officer and President of Research and Development at Pfizer, shared a…
Jan 12, 2025, 07:12 | Insight
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer
Pfizer Inc. has announced promising topline results from its pivotal Phase 3 CREST trial, which…
Dec 30, 2024, 13:08 | Blog
Cathy Eng: Congrats to Pfizer and all the colorectal cancer patients with treatment-naive metastatic CRC
Cathy Eng, Associate Director of Vanderbilt-Ingram Cancer Center, shared a post on LinkedIn: "Congrats to…
Dec 24, 2024, 00:40 | Blog
Chris Boshoff: Targeted treatment regimen for mCRC with a BRAF V600E mutation
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared a post on…
Dec 2, 2024, 18:07 | Blog
Menna Gamal: Going through cancer has shown me the incredible power of love and support
Menna Gamal, Sales Manager at Pfizer, shared a post on LinkedIn: “Going through cancer has…
Nov 26, 2024, 14:18 | Insight
Record breaking $29 Million Raised for VeloSano Cancer Research Accelerator Fund at Cleveland Clinic
The Cleveland Clinic’s VeloSano Cancer Research Accelerator Fund raised a record-breaking $29 million in 2024.…
Nov 23, 2024, 13:40 | Blog
The challenges many rural Americans face when it comes to accessing cancer screening, care, and resources - ACS
American Cancer Society shared on LinkedIn: "In a new series of Front Porch Conversations created with…
Nov 22, 2024, 18:02 | Career
Chris Boshoff: Excited to step into a new role as Pfizer’s Chief Scientific Officer and President Research and Development
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared a post on…
Nov 13, 2024, 11:52 | Blog
Andrew Pannu: Analysis of Big Pharma Therapeutic M&A Deals from 2019 to today
Andrew Pannu, Founder of Sleuth, shared a post on X: "Analysis of Big Pharma Therapeutic M&A…
Nov 12, 2024, 22:58 | Blog
Webinar on Lung Cancer Highlights from ESMO 2024 - SPCC
SPCC (Sharing Progress in Cancer Care) posted the following on LinkedIn: “Our webinar on Lung…
Nov 10, 2024, 02:59 | Blog
Emad Shash: Celebrating the Power of Public-Private Partnerships in Patient Advocacy and Support
Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at…
Oct 31, 2024, 17:06 | Blog
Sarah Louden: The latest insights and breakthroughs from the ESMO USA East meeting
Sarah Louden, Founder and CEO at Total Health Oncology, shared on LinkedIn: ''ESMO USA East…
Oct 28, 2024, 07:42 | Blog
Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'
‘Change the Odds’ with Patrick Dempsey: A Journey of Empowerment in Cancer Awareness Patrick Galen…
Oct 26, 2024, 02:26 | Insight
‘Change the Odds’ with Patrick Dempsey
American Cancer Society shared a post on LinkedIn: “Together with Pfizer and actor Patrick Dempsey,…
Oct 23, 2024, 15:42 | Blog
Aparna Parikh: Diving into the challenges, considerations, and opportunities at HLTH2024
Aparna Parikh, Associate Professor of Medicine at Harvard Medical School and Gastrointestinal Oncologist at Massachusetts…
Oct 23, 2024, 14:45 | Blog
Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer
Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…
Oct 21, 2024, 19:06 | Blog
Sarah Louden: The Latest updates from ESMO at upcoming ESMO USA West
Sarah Louden, Founder and CEO of Total Health | Oncology, shared on LinkedIn: "ESMO USA West.…
Oct 20, 2024, 19:03 | Insight
David D. W. Lee received ASCO Foundation’s EveryGrant
David D. W. Lee, Consultant Clinical Oncologist at University of Malaya Medical Centre, shared a…
Oct 19, 2024, 16:17 | Blog
Aparna Parikh: Addressing the surge in Youth Cancer Diagnoses at HLTH USA 2024
Aparna Parikh shared a post on LinkedIn: "Greater numbers of younger people are being diagnosed with…
Oct 17, 2024, 02:03 | Insight
The American Cancer Society and Pfizer: Breaking Barriers in Cancer Care Disparities
On February 5th, the American Cancer Society (ACS) and Pfizer launched “Change the Odds: Uniting…
Oct 15, 2024, 00:11 | Insight
Akshat Jain: US FDA approves Marstacimab for Hemophilia A or B without inhibitors in adults and adolescents
Akshat Jain shared a post on X: "U.S. FDA approves Pfizer Marstacimab for the treatment of…
Oct 14, 2024, 10:30 | Insight
MHRA Approves Merck and Astellas/Pfizer's Bladder Cancer Combination Therapy
The MHRA has approved the combination of Keytruda (pembrolizumab) and Padcev (enfortumab vedotin) as a…
Oct 12, 2024, 21:55 | Blog
Chris Boshoff: Positive topline overall survival results for our combination regimen in men with metastatic castration-resistant prostate cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared a post on LinkedIn:…
Oct 9, 2024, 17:55 | Blog
Cheri A.: New program to support research focused specifically on breast cancer in men
Cheri A., Founderof Male Breast Cancer Global Alliance, shared a post on Linkedin: '' We…
Oct 6, 2024, 16:18 | Blog
Chris Boshoff: The importance of the patient experience in everything we do
Chris Boshoff shared on Linkedin: '' This week at Pfizer was Patients In Focus, a…
Sep 23, 2024, 14:12 | Blog
Rasha Aboelhassan: Future plans for HER2-positive breast cancer patients
Rasha Aboelhassan shared on Linkedin: ''One of the best things we get from discussing experts…
Sep 14, 2024, 14:36 | Blog
Karen Knudsen: Incredibly grateful to have Pfizer's support of the American Cancer Society National Prostate Cancer Roundtable
Karen Knudsen shared a post by Pfizer on LinkedIn, adding: "We are incredibly grateful to have Pfizer's support…
Sep 14, 2024, 11:47 | Blog
Šarūnas Narbutas: CML AN had a strategic meeting with CEO of Novartis
Šarūnas Narbutas, Director of Resysten Global, shared on LinkedIn: "Today as CML AN we had…
Sep 10, 2024, 00:59 | Blog
Thomas Hagemeijer: Pfizer has launched a D2C platform because of macro trends, brand equity, patient access, and bargaining power
Thomas Hagemeijer, Healthcare Lead at TLGG Consulting, shared on LinkedIn: “Pfizer has just launched a…
Sep 9, 2024, 14:44 | Blog
A special session on 'The Current Landscape of Metastatic Breast Cancer in Ethiopia' by ESHO
ESHO (Ethiopian Society of Hematology and Oncology) shared a post on LinkedIn: ''Earn 1.5 CEU…
Sep 8, 2024, 14:47 | Blog
American Cancer Society National Prostate Cancer Roundtable
American Cancer Society shared on LinkedIn: "Announcing the launch of the American Cancer Society National Prostate…
Sep 8, 2024, 05:44 | Blog
Lung and Breast cancer highlights from the ASCO Annual Meeting 2024 - Sharing Progress in Cancer Care
Sharing Progress in Cancer Care posted on LinkedIn: "Are you interested in lung or breast…
Sep 3, 2024, 12:54 | Blog
OncoInfluencers to Follow on Social Media: Dr. Chris Boshoff
We are excited to spotlight Dr. Chris Boshoff as a distinguished figure in the field…
Aug 30, 2024, 04:49 | Blog
Honoring Robert Salata, a distinguished infectious disease expert
Robert Salata, MD, FACP, FIDSAH was the John H. Hord Professor and Chairman of the…
Aug 20, 2024, 14:47 | Societies
Lung cancer highlights from the 2024 World Conference on Lung Cancer - SPCC
Sharing Progress in Cancer Care (SPCC) shared on LinkedIn: "Mark your calendars: 24 September 2024,…
Aug 19, 2024, 11:40 | Insight
Brian Shields: Pfizer's CROWN study was a highlight of ASCO24
Brian Shields, Creator of KOL Pulse AI, shared on LinkedIn: “Pfizer's CROWN study was a…
Aug 7, 2024, 12:48 | Blog
Highlights on the U.S. - India Cancer Moonshot Dialogue
In June 2023, President Biden and Prime Minister Modi reaffirmed the robust health partnership between…
Aug 5, 2024, 05:34 | Dialogues
Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics
Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…
Jul 22, 2024, 16:46 | Insight
Friends HRD Harmonization Project with Patsy Hinson - Friends of Cancer Research
Friends of Cancer Research shared on X: "It is very important for patients to have…
Jul 18, 2024, 01:38 | Societies
Sarah Louden: The largest summer gathering of oncology healthcare providers in Hawaii
Sarah Louden, Founder and CEO of Total Health, shared on LinkedIn: "Aloha and Mahalo! ASCO…
Jul 12, 2024, 21:44 | Blog
American Cancer Society - Diversity in clinical trials helps ensure that new treatments are effective for everyone
American Cancer Society shared on LinkedIn: "Clinical trials play an important role developing new treatments for…
Jul 10, 2024, 01:00 | Blog
David Fajgenbaum: Every Cure has just completed its most recent round of hiring
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
Jul 2, 2024, 15:28 | Blog
Sarah Louden: 2024 ASCO Direct Puerto Rico is an overwhelming success
Sarah Louden, Founder and CEO of Total Health, shared on LinkedIn: "Excellent! Stupendous! The 2024 ASCO…
Jun 24, 2024, 01:49 | Blog
Lauren Meehan Machos: I am taking a new leadership role at Pfizer
Lauren Meehan Machos, Pfizer Global Oncology, shared a post on X: “Pleased to share I…
Jun 14, 2024, 15:32 | Blog
Whijae Roh: ZNF397 Deficiency in Prostate Cancer
Whijae Roh, Senior Computational Biologist at Pfizer, made the following post on X: "ZNF397 Deficiency…
Jun 12, 2024, 07:44 | Career
Sucheta Guinan: I’m starting a new position as Sr. Director, US HCP Marketing, Oncology at Regeneron!
Sucheta Guinan, Senior Director US HCP Marketing Lead, Oncology at Regeneron, shared on LinkedIn: “I’m…
Jun 11, 2024, 14:31 | Insight
Sofia Tzamarelou: Georgi Ivanov wrote a fantastic piece on ASCO 2024
Sofia Tzamarelou, Senior Consultant at Commetric, shared on LinkedIn: “Our very own Georgi Ivanov wrote…
Jun 4, 2024, 14:59 | Societies
15 Posts From ASCO24 Day 4 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 4, 2024, 12:45 | Blog
Dr. Karen Knudsen and Albert Bourla to discuss how cancer disproportionately impacts ethnic/racial groups - American Cancer Society
American Cancer Society shared on LinkedIn: "At ASCO24, an annual meeting for oncology professionals, Dr. Karen…
Jun 1, 2024, 14:36 | Blog
Albert Bourla: Results from our Phase 3 clinical trial evaluating treatments for patients with advanced ALK-positive NSCLC shared at ASCO24
Albert Bourla, Chairman and Chief Executive Officer of Pfizer, shared a post on LinkedIn: "We’re making…
Jun 1, 2024, 12:12 | Societies
Chris Boshoff: Pfizer announced a 5-year update from our Phase 3 study for patients with ALK+ advanced NSCLC
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "Today…
May 19, 2024, 05:46 | Insight
Nancy Lin: Updated data for Pfizer cdk4-selective inhibitor PF-07220060
Nancy Lin, Associate Chief of Division of Breast Oncology at Susan F. Smith Center for…
May 8, 2024, 13:20 | Drugs
CDK4 inhibitor on the horizon - Oncology Experts
Oncology Experts shared on LinkedIn: "PF-07220060, another CDK4 inhibitor on the horizon. Reported by Pfizer…
May 5, 2024, 12:26 | Blog
Albert Bourla: Some highlights from Pfizer’s 2024 Q1 financial results
Albert Bourla, Chairman and Chief Executive Officer at Pfizer, shared a post on LinkedIn: "Today, I…
May 4, 2024, 11:32 | Blog
Sara Alpsan Johnson: The annual Breath Of Hope Ohio 2024 Gala on May 18th
Sara Alpsan Johnson, Senior Oncology Account Manager GU specialist at Pfizer, shared on LinkedIn: "Did…
May 1, 2024, 12:57 | Blog
Chris Boshoff: Pfizer in ASCO24
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared a post on LinkedIn:…
May 1, 2024, 10:50 | Blog
Chris Boshoff: The U.S. FDA granted full approval for our therapy developed with our partner Genmab
Chris Boshoff shared a post on LinkedIn: "Today, the U.S. FDA granted full approval for our…
Apr 25, 2024, 18:58 | Blog
Herbert Loong: Thanks Harald A. Weber and local Pfizer team for your visit to our Faculty of Medicine of the Chinese University of Hong Kong
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared on X:…
Apr 9, 2024, 15:02 | Blog
Zhen Su: Really excited to see Pfizer leadership donated Bavencio US sales loyalty to American Association for Cancer Research
Zhen Su, CEO at Marengo Therapeutics, recently posted on LinkedIn: "Really excited to see Pfizer…
Apr 9, 2024, 13:17 | Blog
Albert Bourla accepted the AACR Outstanding Achievement Award for Service to Cancer Science and Medicine
American Association for Cancer Research made the following post on LinkedIn: ''Albert Bourla, Chairman and…
Mar 17, 2024, 15:55 | Career
David Hughes: I am excited to take on a new opportunity as a US Medical Director for Pfizer Oncology’s Multiple Myeloma division
David Hughes, US Medical Director - Multiple Myeloma at Pfizer, made the following post on…
Feb 13, 2024, 18:20 | Societies
Karen Knudsen: I am incredibly proud of this new initiative with Pfizer
Karen Knudsen shared a post on LinkedIn: "I am incredibly proud of this new initiative…
Feb 9, 2024, 17:30 | Blog
Chris Boshoff: The U.S. FDA has granted Fast Track designation for our investigational treatment for ER+/HER2- breast cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, posted on LinkedIn: "I’m…
Feb 8, 2024, 17:36 | Blog
Chris Boshoff: Cancer does not discriminate, and neither should cancer care
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, posted on LinkedIn: "I’m…
Jan 14, 2024, 14:49 | Blog
Chris Boshoff: The European Medicines Agency approved our Prostate Cancer combination for men living with metastatic castration-resistant prostate cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "I’m proud…
Jan 12, 2024, 17:07 | Blog
Latest pharma industry updates by Nicolas Schmitz
Nicolas Schmitz, Senior Manager, Strategic Market Analyst at KBI Biopharma, shared a post on LinkedIn:…
Jan 5, 2024, 14:42 | Blog
Edress Darsey: After almost 24 years at Pfizer, today, I say goodbye
Edress Darsey, Global Pediatric Medical Director/Pediatric Clinical Director - Pediatric Center of Excellence at Pfizer,…
Dec 17, 2023, 20:04 | Blog
Margaret Foti: Our heartfelt gratitude to Pfizer for its generous and impactful gift in support of our mission
Margaret Foti made the following post on Twitter: "On behalf of AACR, I want to extend…
Dec 10, 2023, 17:54 | Blog
Christian Rutzer: Roche and Novartis - Basel's Research and Innovation Powerhouses
Christian Rutzer, Deputy Head and Lead Scientist at the CIEB University of Basel, shared on…
Nov 25, 2023, 17:59 | Drugs
Andrew Pannu: The ADC space is blowing up
Andrew Pannu posted on LinkedIn: "The ADC space is blowing up: • More than $125B in…
Nov 18, 2023, 17:16 | Blog
Leon 'Jun' T.: A few interesting observations from the top 25 antibody drug conjugates bone marrow deals
Leon 'Jun' T., Scientific Advisor at Mianus Capital, shared on LinkedIn: "Updated on 2023-11-10 by…
Oct 24, 2023, 15:38 | Opinion
The Max Foundation: Pat Garcia-Gonzalez was recognized and awarded by the President of Kenya, William Samoei Ruto, in honor of Mashujaa Day
Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, recently shared a post by The…
Oct 14, 2023, 17:49 | Drugs
Chris Boshoff: the U.S. FDA approved our targeted combination therapy for the treatment of adult patients with BRAF V600E-mutant metastatic non-small cell lung cancer (NSCLC).
Sep 26, 2023, 19:04 | Insight
Kristina Jenei: This thread on drug shortages is better than most papers I’ve read about the subject.
Quoting Kristina Jenei, Public Health Researcher at the University of British Columbia, on X/Twitter: "This…
Sep 8, 2023, 17:50 | Societies
Julie Gralow: ASCO Asia Pacific Regional Council, Conquer Cancer, the ASCO Foundation, and Pfizer Global Medical Grants announce grants.
Julie Gralow recently shared on LinkedIn: "The American Society of Clinical Oncology (ASCO) Asia Pacific…
Aug 14, 2023, 17:11 | Drugs
Joshua Richter: Another myeloma approval today! Elrexfio
In a post by Joshua Richter, Associate Professor of Medicine at Mount Sinai, it says:…
Aug 14, 2023, 16:41 | Drugs
Chris Boshoff: Science Will Win Against Multiple Myeloma
In a post on LinkedIn by Chris Boshoff, Chief Oncology Research and Development Officer and…
Jul 22, 2023, 19:58 | Career
I'm incredibly honored to share that I have been selected as a finalist for the Washington Global Health Alliance Rising Star Award - Kingsley I. Ndoh
I'm incredibly honored to share that I have been selected as a finalist for the Washington…
Jul 2, 2023, 09:44 | Societies
Conquer Cancer, the ASCO Foundation announced the recipients of pfizer grand
We’re proud to announce the recipients pfizer grants totaling over $1M for researchers working to…
All: 79 Posts: 1 - 100
Special Coverage